Search

Your search keyword '"Monforte A.D."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Monforte A.D." Remove constraint Author: "Monforte A.D."
29 results on '"Monforte A.D."'

Search Results

1. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

2. Safety and efficacy of Daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA Foundation cohorts

4. Associations between HIV-RNA-based indicators and virological and clinical outcomes

5. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe

6. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?

7. The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV Network

10. Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA

11. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

12. Deteriorating renal function and clinical outcomes in HIV-positive persons

13. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration

15. Predicting the risk of cardiovascular disease in HIV-infected patients: The Data collection on Adverse Effects of Anti-HIV Drugs Study

16. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

17. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4(+) T-cell counts (vol 12, pg 325, 2007)

18. Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

19. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

20. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males

21. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

22. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

23. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

24. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

25. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?

26. Carga y factores de riesgo para la neumonía adquirida en la comunidad de Pseudomonas aeruginosa : un estudio multinacional de prevalencia puntual de pacientes hospitalizados

27. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013:a collaborative analysis of cohort studies

28. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus\textendashInfected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)

29. Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy

Catalog

Books, media, physical & digital resources